Report date: Apr 30, 2024 Conflict count: 350192 Publisher: Wiley (Blackwell Publishing) Title count: 478 Conflict count: 16765 ========================================================== Created: 2004-12-23 08:02:11.0 ConfID: 4572082 CauseID: 139804606 OtherID: 3297 JT: Haemophilia MD: SUWANNURAKS, 5 ,2,106,1999,The use of fibrin glue as an operative sealant in dental extraction in bleeding disorder patients DOI: 10.1046/j.1365-2516.1999.00283.x(Journal) (4572082-N ) DOI: 10.1046/j.1365-2516.1999.t01-1-00283.x(Journal) ========================================================== Created: 2008-04-28 21:35:09.0 ConfID: 4624876 CauseID: 552302569 JT: Haemophilia MD: null, 14 ,3,670,2008,Corrigenda DOI: 10.1111/j.1365-2516.2008.01770_2.x(Journal) (4624876-N ) DOI: 10.1111/j.1365-2516.2008.01770_1.x(Journal) ========================================================== Created: 2010-02-25 03:13:05.0 ConfID: 4626181 CauseID: 1024910678 OtherID: 1360551083 JT: Haemophilia MD: null, 16 ,2,413,2010,CORRIGENDA DOI: 10.1111/j.1365-2516.2010.02224_1.x(Journal) (4626181-N ) DOI: 10.1111/j.1365-2516.2010.02224_2.x(Journal) ========================================================== Created: 2004-12-23 08:02:11.0 ConfID: 4648221 CauseID: 139804606 OtherID: 3295 JT: Haemophilia MD: MACNICOL, 5 ,2,139,1999,Does avascular necrosis cause collapse of the dome of the talus in severe haemophilia? DOI: 10.1046/j.1365-2516.1999.00291.x(Journal) (4648221-N ) DOI: 10.1046/j.1365-2516.1999.t01-1-00291.x(Journal) ========================================================== Created: 2009-03-23 05:09:57.0 ConfID: 4758686 CauseID: 759144492 JT: Haemophilia MD: null, 15 ,2,637,2009,Errata DOI: 10.1111/j.1365-2516.2009.02014_3.x(Journal) (4758686-N ) DOI: 10.1111/j.1365-2516.2009.02014_1.x(Journal) ========================================================== Created: 2004-12-23 08:02:11.0 ConfID: 4797969 CauseID: 139804606 OtherID: 3297 JT: Haemophilia MD: BROWN, 5 ,2,127,1999,Emotional reactions of haemophilia health care providers DOI: 10.1046/j.1365-2516.1999.00289.x(Journal) (4797969-N ) DOI: 10.1046/j.1365-2516.1999.t01-1-00289.x(Journal) ========================================================== Created: 2004-12-23 08:02:11.0 ConfID: 4826044 CauseID: 139804606 OtherID: 3295 JT: Haemophilia MD: THORLAND, 5 ,2,101,1999,Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk DOI: 10.1046/j.1365-2516.1999.00303.x(Journal) (4826044-N ) DOI: 10.1046/j.1365-2516.1999.t01-1-00303.x(Journal) ========================================================== Created: 2008-08-28 06:53:54.0 ConfID: 4889703 CauseID: 622681276 JT: Haemophilia MD: null, 14 ,5,1150,2008,Corrigenda DOI: 10.1111/j.1365-2516.2008.01879_2.x(Journal) (4889703-N ) DOI: 10.1111/j.1365-2516.2008.01879_1.x(Journal) ========================================================== Created: 2019-04-04 20:29:20.0 ConfID: 5463344 CauseID: 1442560548 OtherID: 139804584 JT: Haemophilia MD: null, 4 ,s1,25,1998,Panel discussion DOI: 10.1046/j.1365-2516.04.s1.13.x(Journal) (5463344-N ) DOI: 10.1046/j.1365-2516.1998.0040s1025.x(Journal) ========================================================== Created: 2019-04-04 20:29:20.0 ConfID: 5463345 CauseID: 1442560548 OtherID: 139804584 JT: Haemophilia MD: Pickles, 4 ,s1,22,1998,New approaches to funding specialized and expensive treatments for other conditions DOI: 10.1046/j.1365-2516.1998.0040s1022.x(Journal) (5463345-N ) DOI: 10.1046/j.1365-2516.04.s1.12.x(Journal) ========================================================== Created: 2019-04-04 20:29:20.0 ConfID: 5463346 CauseID: 1442560548 OtherID: 139804584 JT: Haemophilia MD: Crump, 4 ,s1,20,1998,UK developments in treating genetic disorders: NSCAG DOI: 10.1046/j.1365-2516.1998.0040s1020.x(Journal) (5463346-N ) DOI: 10.1046/j.1365-2516.04.s1.11.x(Journal) ========================================================== Created: 2019-04-04 20:29:20.0 ConfID: 5463347 CauseID: 1442560548 OtherID: 139804584 JT: Haemophilia MD: Schick, 4 ,s1,18,1998,A regional consensus approach DOI: 10.1046/j.1365-2516.1998.0040s1018.x(Journal) (5463347-N ) DOI: 10.1046/j.1365-2516.04.s1.10.x(Journal) ========================================================== Created: 2019-04-04 20:29:20.0 ConfID: 5463348 CauseID: 1442560548 OtherID: 139804584 JT: Haemophilia MD: Giangrande, 4 ,s1,1,1998,Distribution and treatment of haemophiliacs DOI: 10.1046/j.1365-2516.1998.0040s1001.x(Journal) (5463348-N ) DOI: 10.1046/j.1365-2516.04.s1.2.x(Journal) ========================================================== Created: 2019-04-04 20:29:20.0 ConfID: 5463349 CauseID: 1442560548 OtherID: 139804584 JT: Haemophilia MD: Ludlam, 4 ,s1,13,1998,Funding arrangements within the UK DOI: 10.1046/j.1365-2516.1998.0040s1013.x(Journal) (5463349-N ) DOI: 10.1046/j.1365-2516.04.s1.8.x(Journal) ========================================================== Created: 2019-04-04 20:29:20.0 ConfID: 5463350 CauseID: 1442560548 OtherID: 139804584 JT: Haemophilia MD: Dixon, 4 ,s1,15,1998,Other national models DOI: 10.1046/j.1365-2516.1998.0040s1015.x(Journal) (5463350-N ) DOI: 10.1046/j.1365-2516.04.s1.9.x(Journal) ========================================================== Created: 2019-04-04 20:29:20.0 ConfID: 5463351 CauseID: 1442560548 OtherID: 139804584 JT: Haemophilia MD: Batstone, 4 ,s1,28,1998,Summary DOI: 10.1046/j.1365-2516.1998.0040s1028.x(Journal) (5463351-N ) DOI: 10.1046/j.1365-2516.04.s1.15.x(Journal) ========================================================== Created: 2019-04-04 20:29:20.0 ConfID: 5463352 CauseID: 1442560548 OtherID: 139804584 JT: Haemophilia MD: null, 4 ,s1,26,1998,Group Discussions DOI: 10.1046/j.1365-2516.1998.0040s1026.x(Journal) (5463352-N ) DOI: 10.1046/j.1365-2516.04.s1.14.x(Journal) ========================================================== Created: 2020-10-07 11:21:15.0 ConfID: 5692174 CauseID: 1479391132 OtherID: 139804832 JT: Haemophilia MD: Beeton, 7 ,4,437,2001,Tai Chi Chuan for persons with haemophilia: commentary DOI: 10.1046/j.1365-2516.2001.0538a.x(Journal) (5692174-N ) DOI: 10.1111/j.1365-2516.2001.0538a.x(Journal) ========================================================== Created: 2020-10-07 11:57:35.0 ConfID: 5692176 CauseID: 1479393089 OtherID: 139804810 JT: Haemophilia MD: null, 7 ,1,131,2001,Erratum DOI: 10.1046/j.1365-2516.2001.0460b.x(Journal) (5692176-N ) DOI: 10.1111/j.1365-2516.2001.0460b.x(Journal) ========================================================== Created: 2023-09-10 06:13:11.0 ConfID: 6930150 CauseID: 1588812370 OtherID: 39211289 JT: Haemophilia MD: Teitel, 4 ,5,731,1998,Laboratory and clinical markers of HIV infection in a national haemophilia cohort treated with recombinant factor VIII concentrate DOI: 10.1046/j.1365-2516.1998.00182.x(Journal) (6930150-N ) DOI: 10.1111/j.1365-2516.1998.00182.x(Journal) ========================================================== Created: 2023-09-10 06:13:11.0 ConfID: 6930151 CauseID: 1588812370 OtherID: 39211289 JT: Haemophilia MD: Heeg, 4 ,5,747,1998,Total knee and hip arthroplasty in haemophilic patients DOI: 10.1046/j.1365-2516.1998.00183.x(Journal) (6930151-N ) DOI: 10.1111/j.1365-2516.1998.00183.x(Journal) ========================================================== Created: 2023-09-10 06:13:11.0 ConfID: 6930153 CauseID: 1588812370 OtherID: 39211289 JT: Haemophilia MD: Mandalaki, 4 ,5,766,1998,Does protease inhibitor treatment induce increased bleeding tendency in haemophilia? DOI: 10.1046/j.1365-2516.1998.00177.x(Journal) (6930153-N ) DOI: 10.1111/j.1365-2516.1998.00177.x(Journal) ========================================================== Created: 2023-09-10 06:13:11.0 ConfID: 6930154 CauseID: 1588812370 OtherID: 39211289 JT: Haemophilia MD: Fields, 4 ,5,699,1998,Gene therapy for haemophilia: how far have we come? DOI: 10.1046/j.1365-2516.1998.00175.x(Journal) (6930154-N ) DOI: 10.1111/j.1365-2516.1998.00175.x(Journal) ========================================================== Created: 2023-09-10 06:13:11.0 ConfID: 6930155 CauseID: 1588812370 OtherID: 39211289 JT: Haemophilia MD: Hoots, 4 ,5,704,1998,Clotting factor concentrates and immune function in haemophilic patients DOI: 10.1046/j.1365-2516.1998.00172.x(Journal) (6930155-N ) DOI: 10.1111/j.1365-2516.1998.00172.x(Journal) ========================================================== Created: 2023-09-25 14:50:24.0 ConfID: 6937116 CauseID: 1590646992 OtherID: 139804583 JT: Haemophilia MD: null, 4 ,s2,64,1998,WHO/WFH Recomendations, June 1997 DOI: 10.1046/j.1365-2516.1998.0040s2064.x(Journal) (6937116-N ) DOI: 10.1046/j.1365-2516.4.s2.24.x(Journal) ========================================================== Created: 2023-10-11 13:46:19.0 ConfID: 6960561 CauseID: 1592609389 JT: Haemophilia MD: Rodriguez‐Merchan, 10 ,1,114,2004,The haemophilic joints: new perspectives DOI: 10.1046/j.1365-2516.2003.00858.x(Journal) (6960561-N ) DOI: 10.1046/j.1365-2516.2003.00859.x(Journal) ========================================================== Created: 2023-10-16 10:02:09.0 ConfID: 6963856 CauseID: 1593199184 OtherID: 139804832 JT: Haemophilia MD: Kallas, 7 ,4,375,2001,von Willebrand factor in factor VIII concentrates protects against neutralization by factor VIII antibodies of haemophilia A patients DOI: 10.1046/j.1365-2516.2001.00530.x(Journal) (6963856-N ) DOI: 10.1111/j.1365-2516.2001.00530.x(Journal) ========================================================== Created: 2023-10-16 10:02:09.0 ConfID: 6963857 CauseID: 1593199184 OtherID: 139804832 JT: Haemophilia MD: Hacker, 7 ,4,392,2001,Barriers to compliance with prophylaxis therapy in haemophilia DOI: 10.1046/j.1365-2516.2001.00534.x(Journal) (6963857-N ) DOI: 10.1111/j.1365-2516.2001.00534.x(Journal) ========================================================== Created: 2023-10-16 10:02:09.0 ConfID: 6963858 CauseID: 1593199184 OtherID: 139804832 JT: Haemophilia MD: Gensana, 7 ,4,369,2001,Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIII DOI: 10.1046/j.1365-2516.2001.00526.x(Journal) (6963858-N ) DOI: 10.1111/j.1365-2516.2001.00526.x(Journal) ========================================================== Created: 2023-10-16 10:02:09.0 ConfID: 6963859 CauseID: 1593199184 OtherID: 139804832 JT: Haemophilia MD: Theophilus, 7 ,4,381,2001,Site and type of mutations in the factor VIII gene in patients and carriers of haemophilia A DOI: 10.1046/j.1365-2516.2001.00528.x(Journal) (6963859-N ) DOI: 10.1111/j.1365-2516.2001.00528.x(Journal) ========================================================== Created: 2023-10-16 10:02:09.0 ConfID: 6963860 CauseID: 1593199184 OtherID: 139804832 JT: Haemophilia MD: Acquila, 7 ,4,416,2001,A new strategy for prenatal diagnosis in a sporadic haemophilia B family DOI: 10.1046/j.1365-2516.2001.00514.x(Journal) (6963860-N ) DOI: 10.1111/j.1365-2516.2001.00514.x(Journal) ========================================================== Created: 2023-10-16 10:02:09.0 ConfID: 6963861 CauseID: 1593199184 OtherID: 139804832 JT: Haemophilia MD: Godreuil, 7 ,4,428,2001,Acquired haemophilia in the elderly is a severe disease: report of five new cases DOI: 10.1046/j.1365-2516.2001.00531.x(Journal) (6963861-N ) DOI: 10.1111/j.1365-2516.2001.00531.x(Journal) ========================================================== Created: 2023-10-16 10:02:09.0 ConfID: 6963862 CauseID: 1593199184 OtherID: 139804832 JT: Haemophilia MD: Billon, 7 ,4,433,2001,A case of chronic myelomonocytic leukaemia and factor XI deficiency with a circulating anticoagulant DOI: 10.1046/j.1365-2516.2001.00523.x(Journal) (6963862-N ) DOI: 10.1111/j.1365-2516.2001.00523.x(Journal) ========================================================== Created: 2023-10-16 10:02:09.0 ConfID: 6963863 CauseID: 1593199184 OtherID: 139804832 JT: Haemophilia MD: Barnes, 7 ,4,439,2001,Induction of immune tolerance and suppression of anaphylaxis in a child with haemophilia B by simple plasmapheresis and antigen exposure: progress report DOI: 10.1046/j.1365-2516.2001.0538c.x(Journal) (6963863-N ) DOI: 10.1111/j.1365-2516.2001.0538c.x(Journal) ========================================================== Created: 2023-10-16 10:02:09.0 ConfID: 6963864 CauseID: 1593199184 OtherID: 139804832 JT: Haemophilia MD: Danusantoso, 7 ,4,437,2001,Tai Chi Chuan for people with haemophilia DOI: 10.1046/j.1365-2516.2001.0538b.x(Journal) (6963864-N ) DOI: 10.1111/j.1365-2516.2001.0538b.x(Journal) ========================================================== Created: 2023-10-16 10:02:09.0 ConfID: 6963865 CauseID: 1593199184 OtherID: 139804832 JT: Haemophilia MD: null, 7 ,4,411,2001,Decisions and dilemmas: resolving ethical, medical and economic issues facing haemophilia care DOI: 10.1046/j.1365-2516.2001.00533.x(Journal) (6963865-N ) DOI: 10.1111/j.1365-2516.2001.00533.x(Journal) ========================================================== Created: 2023-10-16 10:02:09.0 ConfID: 6963866 CauseID: 1593199184 OtherID: 139804832 JT: Haemophilia MD: null, 7 ,4,401,2001,Symposium in memory of Professor Inga Marie Nilsson DOI: 10.1046/j.1365-2516.2001.00524.x(Journal) (6963866-N ) DOI: 10.1111/j.1365-2516.2001.00524.x(Journal) ========================================================== Created: 2023-10-16 10:02:09.0 ConfID: 6963867 CauseID: 1593199184 OtherID: 139804832 JT: Haemophilia MD: Makris, 7 ,4,339,2001,Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia DOI: 10.1046/j.1365-2516.2001.00527.x(Journal) (6963867-N ) DOI: 10.1111/j.1365-2516.2001.00527.x(Journal) ========================================================== Created: 2023-10-16 10:02:34.0 ConfID: 6963876 CauseID: 1593199240 OtherID: 139804810 JT: Haemophilia MD: Miller, 7 ,1,91,2001,The responsibility of separating truth from myth to patient and family DOI: 10.1046/j.1365-2516.2001.00472.x(Journal) (6963876-N ) DOI: 10.1111/j.1365-2516.2001.00472.x(Journal) ========================================================== Created: 2023-10-16 10:02:34.0 ConfID: 6963877 CauseID: 1593199240 OtherID: 139804810 JT: Haemophilia MD: Oranwiroon, 7 ,1,20,2001,Determination of haemophilia A carrier status by mutation analysis DOI: 10.1046/j.1365-2516.2001.00453.x(Journal) (6963877-N ) DOI: 10.1111/j.1365-2516.2001.00453.x(Journal) ========================================================== Created: 2023-10-16 10:02:34.0 ConfID: 6963878 CauseID: 1593199240 OtherID: 139804810 JT: Haemophilia MD: Penner, 7 ,1,103,2001,Haemophilic patients with inhibitors to factor VIII or IX: variables affecting treatment response DOI: 10.1046/j.1365-2516.2001.00473.x(Journal) (6963878-N ) DOI: 10.1111/j.1365-2516.2001.00473.x(Journal) ========================================================== Created: 2023-10-16 10:02:34.0 ConfID: 6963879 CauseID: 1593199240 OtherID: 139804810 JT: Haemophilia MD: Petrini, 7 ,1,99,2001,What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B? DOI: 10.1046/j.1365-2516.2001.00471.x(Journal) (6963879-N ) DOI: 10.1111/j.1365-2516.2001.00471.x(Journal) ========================================================== Created: 2023-10-16 10:02:34.0 ConfID: 6963880 CauseID: 1593199240 OtherID: 139804810 JT: Haemophilia MD: Ishiguro, 7 ,1,127,2001,Rapidly destructive arthropathy of the hip in haemophilia DOI: 10.1046/j.1365-2516.2001.00475.x(Journal) (6963880-N ) DOI: 10.1111/j.1365-2516.2001.00475.x(Journal) ========================================================== Created: 2023-10-16 10:02:34.0 ConfID: 6963881 CauseID: 1593199240 OtherID: 139804810 JT: Haemophilia MD: Ebeling, 7 ,1,42,2001,Viral markers and use of factor products among Finnish patients with bleeding disorders DOI: 10.1046/j.1365-2516.2001.00477.x(Journal) (6963881-N ) DOI: 10.1111/j.1365-2516.2001.00477.x(Journal) ========================================================== Created: 2023-10-16 10:02:34.0 ConfID: 6963882 CauseID: 1593199240 OtherID: 139804810 JT: Haemophilia MD: Cid, 7 ,1,39,2001,A comparison of FVII:C and FVIIa assays for the monitoring of recombinant factor VIIa treatment DOI: 10.1046/j.1365-2516.2001.00478.x(Journal) (6963882-N ) DOI: 10.1111/j.1365-2516.2001.00478.x(Journal) ========================================================== Created: 2023-10-16 10:02:34.0 ConfID: 6963883 CauseID: 1593199240 OtherID: 139804810 JT: Haemophilia MD: Minor, 7 ,1,114,2001,Are recombinant products really infection risk free? DOI: 10.1046/j.1365-2516.2001.00467.x(Journal) (6963883-N ) DOI: 10.1111/j.1365-2516.2001.00467.x(Journal) ========================================================== Created: 2023-10-16 10:02:34.0 ConfID: 6963884 CauseID: 1593199240 OtherID: 139804810 JT: Haemophilia MD: Srivastava, 7 ,1,117,2001,Choice of factor concentrates for haemophilia: a developing world perspective DOI: 10.1046/j.1365-2516.2001.00468.x(Journal) (6963884-N ) DOI: 10.1111/j.1365-2516.2001.00468.x(Journal) ========================================================== Created: 2023-10-16 10:02:34.0 ConfID: 6963885 CauseID: 1593199240 OtherID: 139804810 JT: Haemophilia MD: Aguilar, 7 ,1,6,2001,An emerging role for interferon in haemophiliacs with chronic hepatitis C? DOI: 10.1046/j.1365-2516.2001.00462.x(Journal) (6963885-N ) DOI: 10.1111/j.1365-2516.2001.00462.x(Journal) ========================================================== Created: 2023-10-16 10:03:15.0 ConfID: 6963948 CauseID: 1593199357 JT: Haemophilia MD: null, 7 ,6,605,2001,A History of Blood Coagulation DOI: 10.1046/j.1365-2516.2001.0569b.x(Journal) (6963948-N ) DOI: 10.1046/j.1365-2516.2001.0569a.x(Journal)